1834P Exposure-efficacy analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial
| Autor: | Azad, A.A., Lincha, V.R., Hadigol, M., Hoffman, J., Agarwal, N., Matsubara, N., Wang, Y., DeAnnuntis, L., Zohren, F., Wang, D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S992-S993 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|